Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients
- 18 November 2009
- journal article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 18 (12), 1531-1538
- https://doi.org/10.1007/s00520-009-0775-3
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Opioid medications and longitudinal risk of delirium in hospitalized cancer patientsCancer, 2007
- Practice Guidelines for Transdermal Opioids in Malignant PainDrugs, 2004
- Constipation?modern laxative therapySupportive Care in Cancer, 2003
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- Dose‐Related Antagonism of the Emetic Effect of Morphine by Methylnaltrexone in DogsThe Journal of Clinical Pharmacology, 1993
- A long-term survey of morphine in cancer pain patientsJournal of Pain and Symptom Management, 1992
- The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextro-propoxyphene/paracetamol tablets in patients with severe osteoarthritis of the hipsCurrent Medical Research and Opinion, 1992
- Modulation of HMG-CoA reductase activity by pantetheine/pantethineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Management of Cancer Pain With Oral Controlled‐Release Morphine SulfateThe Journal of Clinical Pharmacology, 1987
- Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestineLife Sciences, 1982